MSB 5.24% $1.11 mesoblast limited

Cell Therapy News/Articles, page-5368

  1. 6,118 Posts.
    lightbulb Created with Sketch. 1053
    Thanks for sharing the link @col69

    Here is the news.

    JCR Pharmaceuticals Co., Ltd. (TSE 4552: Chairman and President Shin Ashida, “JCR” announced today about capital expenditures to expand the manufacturing area to increase production capacity for TEMCELL® HS Inj.
    Screenshot_20200804_081647.jpg
    Screenshot_20200804_081659.jpg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.